title: Superficial venous thrombophlebitis associated with pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B.
authors.forename: Maria
authors.initials: M
authors.lastname: Kalafateli
authors.forename: Christos
authors.initials: C
authors.lastname: Triantos
authors.forename: Stavros K
authors.initials: SK
authors.lastname: Kakkos
authors.forename: Athina
authors.initials: A
authors.lastname: Mougiou
authors.forename: Chryssoula
authors.initials: C
authors.lastname: Labropoulou-Karatza
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D014463:Ultrasonography
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a